已关闭
收藏
Vitronectin (VTN-N) is a recombinant human protein that provides a defined surface for feeder-free culture of human pluripotent stem cells (PSCs). When used with Essential 8™ Medium (A1517001), vitronectin (VTN-N) has been proven to maintain pluripotency and normal growth characteristics in multiple PSC lines. In addition, vitronectin (VTN-N) has been shown to support PSC growth for >50 passages without any signs of karyotypic abnormalities and to maintain the ability of PSCs to differentiate into all three germ line lineages. As published by Guokai Chen et al. (1) in the laboratory of James Thomson, the VTN-N variant of vitronectin supports human pluripotent stem cell attachment and survival better than wild-type vitronectin when used in conjunction with Essential 8™ Medium.
Vitronectin (VTN-N) is:
• Optimized—designed in the laboratory of James Thomson for use with Essential 8™ Medium
• Defined—for reduced variability in your PSC cultures
• Cost effective—for economical and scalable PSC culture
Optimized and Defined Surface
Unlike standard basement membrane extracts (BMEs), vitronectin (VTN-N) was designed in the laboratory of James Thomson for use with Essential 8™ Medium and has been shown to support human pluripotent stem cell attachment and survival better than wild type vitronectin. Vitronectin (VTN-N) provides an optimal environment for feeder-free pluripotent stem cell culture.
Reduce Variability
Vitronectin (VTN-N) is a defined, recombinant human protein that reduces variability in your PSC cultures compared to human-plasma derived vitronectin and standard basement membrane extracts (BMEs).
Cost Effective
When used with Essential 8™ Medium, vitronectin (VTN-N) provides a cost effective, defined system for feeder free culture of human pluripotent stem cells (PSCs).
Commercialized in Partnership with Cellular Dynamics International.
赛默飞mRNA疫苗整体解决方案.pdf
创新药出海白皮书.pdf
创新药出海白皮书.pdf
化学药物分析整体解决方案.pdf
化学药物分析整体解决方案.pdf
化学药物分析整体解决方案.pdf
赛默飞疫苗整体解决方案.pdf
赛默飞制药挤出与分析解决方案.pdf
中药分析完整解决方案.pdf
中药分析完整解决方案.pdf
赛默飞细胞与基因治疗整体解决方案.pdf
赛默飞细胞与基因治疗整体解决方案.pdf
赛默飞生物药解决方案概览.pdf
赛默飞抗体药物整体解决方案.pdf